Richard F. Riedel
Duke University(US)Duke Medical Center(US)Duke University Health System(US)Duke Cancer Institute
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Vascular Tumors and Angiosarcomas, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Cardiac tumors and thrombi
Most-Cited Works
- → Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial(2017)1,375 cited
- → NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors(2010)1,215 cited
- → Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology(2022)1,120 cited
- → Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology(2018)724 cited
- → Genomic signatures to guide the use of chemotherapeutics(2006)593 cited
- → Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development(1999)558 cited